About
genOway is a biotechnology company that specializes in developing genetically modified research models with strong added value for the biopharmaceutical industries and academic researches. genOway is a leader in its market. It builds its development on the combination of a large and exclusive technological platform and a strong intellectual property combining operating patents and licenses. genOway struck several commercial contracts with pharmaceutical industry leaders (Janssen R&D, GSK, Pfizer, etc.), and with the most prestigious academic research centers (King's College and Manchester in England, Harvard, Caltech and National Institute of Health in the United States, the Institut Pasteur in France, the NGFN, etc.).
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 163 investors are based in Lyon, Rhone-Alpes, France.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Lyon, France
Contact Information
Find more investors like genOway
Search Investors